DNA X, Inc.
SONM
$4.75
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.34M | -8.89M | -4.75M | -7.48M | 458.00K |
| Total Depreciation and Amortization | -- | 1.50M | 952.00K | 797.00K | 1.06M |
| Total Amortization of Deferred Charges | 43.00K | 943.00K | 0.00 | 1.08M | 41.00K |
| Total Other Non-Cash Items | -15.08M | -174.00K | 306.00K | 799.00K | -5.08M |
| Change in Net Operating Assets | 5.23M | 4.62M | -3.54M | -87.00K | -6.08M |
| Cash from Operations | -3.47M | -2.00M | -7.03M | -4.88M | -9.61M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 3.36M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.36M | -- | -- | -- | -- |
| Total Debt Issued | -- | 1.26M | 2.32M | -51.00K | 2.84M |
| Total Debt Repaid | -- | 36.00K | 0.00 | -591.00K | -- |
| Issuance of Common Stock | -- | -126.00K | 4.85M | 5.42M | 3.54M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1.17M | 7.17M | 4.77M | 6.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.00K | -834.00K | 131.00K | -109.00K | -3.23M |